Found: 54
Select item for more details and to access through your institution.
Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 11, p. 1, doi. 10.1093/ofid/ofac618
- By:
- Publication type:
- Article
Hepatitis E Virus-Associated Meningoencephalitis in a Lung Transplant Recipient Diagnosed by Clinical Metagenomic Sequencing.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 3, p. 1, doi. 10.1093/ofid/ofx109
- By:
- Publication type:
- Article
The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
- Published in:
- Open Forum Infectious Diseases, 2014, v. 1, n. 3, p. 1, doi. 10.1093/ofid/ofu104
- By:
- Publication type:
- Article
Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32551-2
- By:
- Publication type:
- Article
Examination of Polypharmacy Trajectories Among HIV-Positive and HIV-Negative Men in an Ongoing Longitudinal Cohort from 2004 to 2016.
- Published in:
- AIDS Patient Care & STDs, 2019, v. 33, n. 8, p. 354, doi. 10.1089/apc.2019.0057
- By:
- Publication type:
- Article
Predictors of Pneumonia Severity in HIV-Infected Adults Admitted to an Urban Public Hospital.
- Published in:
- AIDS Patient Care & STDs, 2011, v. 25, n. 5, p. 273, doi. 10.1089/apc.2010.0365
- By:
- Publication type:
- Article
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 4, p. 1, doi. 10.1371/journal.ppat.1011680
- By:
- Publication type:
- Article
Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.945706
- By:
- Publication type:
- Article
Sociodemographic and clinical characteristics of persons who experienced spontaneous hepatitis C viral clearance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Recurrence of Symptoms Following a 2-Day Symptom Free Period in Patients With COVID-19.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 10, p. e2238867, doi. 10.1001/jamanetworkopen.2022.38867
- By:
- Publication type:
- Article
COVID-19 Therapeutics for Nonhospitalized Patients—Updates and Future Directions.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 16, p. 1519, doi. 10.1001/jama.2023.19542
- By:
- Publication type:
- Article
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 5, p. 658, doi. 10.7326/M22-3428
- By:
- Publication type:
- Article
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 3, p. 348, doi. 10.7326/M22-2381
- By:
- Publication type:
- Article
Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons.
- Published in:
- Journal of International Medical Research, 2017, v. 45, n. 6, p. 1693, doi. 10.1177/0300060517708919
- By:
- Publication type:
- Article
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e2310039, doi. 10.1001/jamanetworkopen.2023.10039
- By:
- Publication type:
- Article
Barriers to hepatitis C direct‐acting antiviral therapy among HIV/hepatitis C virus‐coinfected persons.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 4, p. 1095, doi. 10.1111/jgh.15228
- By:
- Publication type:
- Article
Sexual behavior is linked to changes in gut microbiome and systemic inflammation that lead to HIV-1 infection in men who have sex with men.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06816-z
- By:
- Publication type:
- Article
Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 4, p. 557, doi. 10.1093/cid/cix359
- By:
- Publication type:
- Article
Comparative Pharmacokinetics of Tixagevimab/Cilgavimab (AZD7442) Administered Intravenously Versus Intramuscularly in Symptomatic SARS‐CoV‐2 Infection.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1207, doi. 10.1002/cpt.2706
- By:
- Publication type:
- Article
Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD).
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-022-00535-x
- By:
- Publication type:
- Article
Association of HIV Serostatus and Inflammation With Ascending Aortic Size.
- Published in:
- 2022
- By:
- Publication type:
- journal article
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 4, p. 920, doi. 10.1093/cid/ciae324
- By:
- Publication type:
- Article
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 941, doi. 10.1093/cid/ciad342
- By:
- Publication type:
- Article
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 4, p. 734, doi. 10.1093/cid/ciac818
- By:
- Publication type:
- Article
Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV).
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e571, doi. 10.1093/cid/ciac708
- By:
- Publication type:
- Article
TIXAGEVIMAB/CILGAVIMAB IM AND IV FOR COVID-19: A RANDOMIZED CONTROLLED ACTIV-2 TRIAL.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 225
- By:
- Publication type:
- Article
REDUCTION IN HIV RESERVOIR MARKERS WITH GAG/POL/IL-12 DNA THERAPEUTIC VACCINATION.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 169
- By:
- Publication type:
- Article
IMMUNE FEATURES ASSOCIATED WITH HIGHER T CELL RESPONSES TO AN HIV THERAPEUTIC VACCINE.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 161
- By:
- Publication type:
- Article
PLASMA ANTIBODY AND N ANTIGEN STATUS PREDICT OUTCOMES IN OUTPATIENTS WITH COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 114
- By:
- Publication type:
- Article
CHARACTERIZATION OF SINGLE VERSUS DUAL ACTIVE mAB AGAINST SARS-CoV-2.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 69
- By:
- Publication type:
- Article
SYMPTOM AND VIRAL REBOUND IN UNTREATED COVID-19 INFECTION.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 70
- By:
- Publication type:
- Article
SAFETY AND EFFICACY OF INHALED INTERFERON-β1A (SNG001) IN OUTPATIENTS WITH COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 69
- By:
- Publication type:
- Article
FUTURE DIRECTIONS IN OUTPATIENT THERAPY FOR MILD TO MODERATE COVID-19.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 38
- By:
- Publication type:
- Article
Determining the lower limit of detection required for HCV viral load assay for test of cure following direct‐acting antiviral‐based treatment regimens: Evidence from a global data set.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 474, doi. 10.1111/jvh.13672
- By:
- Publication type:
- Article
Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus‐co‐infected patients in Myanmar.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 1, p. 147, doi. 10.1111/jvh.13405
- By:
- Publication type:
- Article
Cohort study of familial viral hepatitis and risks of paediatric cancers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prevalence and trends of polypharmacy among HIV-positive and -negative men in the Multicenter AIDS Cohort Study from 2004 to 2016.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203890
- By:
- Publication type:
- Article
Prepandemic Metabolic Correlates of Coronavirus Disease 2019 (COVID-19) Severity and Long COVID Incidence in People Living With HIV.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 4, p. 912, doi. 10.1093/infdis/jiae362
- By:
- Publication type:
- Article
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. 394, doi. 10.1093/infdis/jiae192
- By:
- Publication type:
- Article
Response to Drs de Grooth and Parienti.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 5, p. 1596, doi. 10.1093/infdis/jiae053
- By:
- Publication type:
- Article
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S101, doi. 10.1093/infdis/jiad285
- By:
- Publication type:
- Article
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S83, doi. 10.1093/infdis/jiad300
- By:
- Publication type:
- Article
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S117, doi. 10.1093/infdis/jiad287
- By:
- Publication type:
- Article
Long COVID After Bamlanivimab Treatment.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S126, doi. 10.1093/infdis/jiad286
- By:
- Publication type:
- Article
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S77, doi. 10.1093/infdis/jiad246
- By:
- Publication type:
- Article
Variant-Specific Viral Kinetics in Acute COVID-19.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S136, doi. 10.1093/infdis/jiad314
- By:
- Publication type:
- Article
Immune Status and SARS-CoV-2 Viral Dynamics.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S111, doi. 10.1093/infdis/jiad200
- By:
- Publication type:
- Article
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S92, doi. 10.1093/infdis/jiad209
- By:
- Publication type:
- Article